Bridging the Translational Science Divide
Aug 01, 2021•40 min
Episode description
Pete Schultz, CEO of Scripps Research, sits down with Neil to discuss his efforts to create a self-sustaining nonprofit drug discovery and development institute and it’s work to advance small molecule regenerative therapies from the lab to the clinic.
For the best experience, listen in Metacast app for iOS or Android
